Fig. 5. Cytosol immunodepleted of PKC
does not support PCTV budding but does support protein-vesicle budding. (A) PCTVs were budded from ER using native cytosol and ER treated with IgG (NC), cytosol immunodepleted of PKC
(–PKC
), or cytosol immunodepleted of PKC
to which either 2.5 µg recombinant PKC
(+rPKC
) or 2.5 µg PKC
(+rPKC
) was added. For NC, ER treated with 10 mM HEPES, pH 7.2 was used. When PKC
-depleted cytosol was used, the accompanying ER was treated with 2 M urea. Data are the mean ± s.e.m., n=4. P values indicate differences between the means of –PKC
and NC or +rPKC
, or the difference between +rPKC
and NC or +rPKC
. (B) PCTV and protein vesicles were budded from [14C]TAG and [3H]protein loaded ER using cytosol treated with IgG (NC) or cytosol immunodepleted of PKC
(–PKC
). After incubation (Materials and Methods), PCTV and protein vesicles were separated on a continuous sucrose gradient. The gradient was resolved into 20 fractions of 0.5 ml each. The first three fractions were considered to be PCTV and fractions 8 to 10 were considered to be protein vesicles. The TAG was extracted from the PCTV-containing fractions and the proteins collected from the protein-vesicle fractions after TCA precipitation. PCTV-budding activity is shown on the left and protein-vesicle budding activity on the right.